In vivo metabolism of 4-fluorobenzoic acid [(5-nitro-2-furanyl)methylene] hydrazide in rats.
It is known that substituted hydrazide hydrazone derivatives have several biological and pharmacological activities; there is limited literature on the metabolism of hydrazide hydrazones in rats. In our previous study, 4-fluorobenzoic acid [(5-nitro-2-furanyl)methylene]hydrazide (S) was found active against Staphylococcus aureus ATCC 29213. Therefore, we planned to study the in vivo metabolism of S in rats. The substrate was administered in doses of 50 mg/kg or 100 mg/kg intraperitoneally. Blood samples were collected at 0, 5, 15, 30, 45 min and 1, 1.5, 2, 4, 8, 12, 24, 48 h after administration. The substrate and its potential metabolites were separated using HPLC on a reverse phase system. 4-Fluorobenzoic acid and one unidentified metabolite were detected together with substrate.
Gülerman
N N
NN
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Istanbul, Turkey.
Oruç
E E
EE
Kartal
F
F
Rollas
S
S
D000818:Animals; D001565:Benzoates / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D006835:Hydrazones / Q000378:metabolism*; D008297:Male; D051381:Rats; D017208:Rats, Wistar
D001565:Benzoates; D006835:Hydrazones; C022893:4-fluorobenzoic acid